These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9163696)

  • 1. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.
    Pfau W; Schmeiser HH; Wiessler M
    Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
    Arlt VM; Wiessler M; Schmeiser HH
    Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
    Broschard TH; Wiessler M; Schmeiser HH
    Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid.
    Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH
    Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
    Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
    Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adduct formation of aristolochic acid I and II in vitro and in vivo.
    Schmeiser HH; Schoepe KB; Wiessler M
    Carcinogenesis; 1988 Feb; 9(2):297-303. PubMed ID: 3338114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen.
    Pfau W; Schmeiser HH; Wiessler M
    Chem Res Toxicol; 1991; 4(5):581-6. PubMed ID: 1665354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
    Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
    Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.